{"schema_version":"1.0","type":"article","title":"🧬 生技投資圈｜不是更多新聞，是一套生技醫藥判斷系統","url":"https://drugnews.com.tw/articles/2026-05-28-biotech-investment-judgment-system.html","markdown_url":"https://drugnews.com.tw/articles/2026-05-28-biotech-investment-judgment-system.md","lang":"zh-Hant","date":"2026-05-28","publish_at":"2026-05-28T10:30:00+08:00","updated_at":"2026-05-28","category":"商業分析系列","topic":"商業分析系列","tags":["Dcard","免費文章","BD","生技投資"],"summary":"生技新聞很多。但真正難的不是「知道發生了什麼」，而是看懂：🔍 這件事到底改變了公司的基本面嗎？一個臨床結果，是降低失敗風險，還是市場短線情緒？一個授權案，是有真實商業價值，還是只是在包裝題材？一家公司","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"Dcard 原圖：生技投資圈｜不是更多新聞，是一套生技醫藥判斷系統","url":"https://drugnews.com.tw/assets/articles/biotech-investment-judgment-system/dcard-01.webp"}],"cover_image":"https://drugnews.com.tw/assets/articles/biotech-investment-judgment-system/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-05-28）。🧬 生技投資圈｜不是更多新聞，是一套生技醫藥判斷系統。https://drugnews.com.tw/articles/2026-05-28-biotech-investment-judgment-system.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-05-28-biotech-investment-judgment-system-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}